DDI Study Between Dorzagliatin and Rifampicin

Clinical trial NCT04080609 · COMPLETED

Trial details

NCT number: NCT04080609
Sponsor: Hua Medicine Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Interaction

Start date: 2018-03-27
Primary completion: 2018-04-17
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.